ParcelBio

Drug Discovery · San Francisco, CA · Founded 2023 · Privately Held (backing)

Developer of a programmable technology designed to deliver messenger ribonucleic acid to diverse cell types in the body. ParcelBio is based in San Francisco, CA and was founded in 2023. It was valued at $41.2 million at its seed round in Mar 2026, the last priced event on record. It has raised $13.7 million across 1 recorded round; the latest was a seed round in May 2024.

PMV mark · valuation
$41.2M
Oct 2026
Priced at
its seed round
Mar 2026
Total raised
$13.7M
Last round
Seed Round
May 2024
What is ParcelBio worth?
$41.2MPrivateMarketView mark · Oct 2026

Valued at $41.2M at its seed round, Mar 2026. Nothing has traded since.

Free account
More of ParcelBio with a free account
  • ·The complete investor list: 13 names
  • ·Watch ParcelBio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

ParcelBio funding history

1 rounds
DateRoundRaisedPost-money
May 2024Seed Round—▮
Unlock post-money valuations

Membership and data by Private Market View

ParcelBio valuation

ParcelBio was valued at $41.2 million at its seed round in Mar 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has ParcelBio raised?

ParcelBio has raised $13.7 million in total; 1 of its rounds is on record. The most recent was a seed round in May 2024.

Comparable companies

Comparable drug discovery names by valuation on PrivateMarketView: Hinge Bio ($46 million), Persephone Biosciences ($37.3 million) and Solarea Bio ($37 million).

How ParcelBio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For ParcelBio, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about ParcelBio

What is ParcelBio worth?
ParcelBio is valued at $41.2M as of Oct 2026. Valued at $41.2M at its seed round, Mar 2026. Nothing has traded since.
How much has ParcelBio raised?
ParcelBio has raised $13.7M in total funding across 1 recorded rounds.
When did ParcelBio last raise?
ParcelBio last raised in May 2024 (Seed Round).